Smith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer.


Medical technology company Smith & Nephew said on Monday that it has appointed Ajay Dhankhar as chief corporate development & strategy officer with immediate effect.

  • Smith & Nephew
  • 23 June 2025 13:39:48
Smith & Nephew

Source: Sharecast

It said that as both a senior management consultant and investment banker, Dhankhar has advised CEOs and boards at some of the world's leading healthcare companies, helping deliver "substantial shareholder value".

His experience includes 25 years with McKinsey & Company where he was a senior partner and held multiple leadership roles including Global Head of Strategy across all industries, Global Head of Strategy and M&A for Life Sciences and Global Head of Life Sciences R&D.

Following that, Dhankhar served as a managing director in the financial advisory healthcare group of Lazard, where he was the Global Head of Medical Technology, Diagnostics and Tools.

More recently, he founded and led Bluish Capital, a strategy and financial advisory firm focused on deploying growth capital to support high quality, recently FDA approved assets.

Chief executive Deepak Nath said: "Ajay’s unique blend of scientific rigor, strategic insight, business development, integrations, and operational excellence, combined with his entrepreneurial leadership style, makes him exceptionally well-suited to help shape our future. We are pleased to have him join our leadership team at this exciting time for the company."


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: 0.95 ( 0.01 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.